Literature DB >> 6502193

Removable high intensity iridium-192 brain implants. Technique and in vivo measurements in canine brain.

W Sewchand, P P Amin, R E Drzymala, O M Salazar, M Salcman, G M Samaras, E Botero.   

Abstract

A preclinical evaluation of the technical details and dosimetry for temporary high intensity 192Ir brain implants is presented. The canine brain was used for this quality assurance study in which direct in vivo dose measurements were done by thermoluminescent dosimetry (TLD rods). Precise and reproducible positioning of the TLD rods and 192Ir ribbons were assured by simple accessories which can be utilized in the clinical situation. The neurosurgical procedure for this non-routine interstitial implant of the brain, suitability of type and size of afterloading cannulas and facility for firmly anchoring them to the scalp, and comparison of measured doses with computer-predicted values are details assured by the canine study. Agreement between the in vivo determination and computer-generated doses was consistently in the range 2-5%. Data derived from this preclinical evaluation are currently used in both stereotactic and non-stereotactic brain implants at our institution. Details are presented for the implant procedure, dose measurements and brachytherapy planning for multiple ribbons. The latter incorporates direct interaction on computed tomography (CT) images for a hypothetical patient case.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502193     DOI: 10.1007/bf00253269

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  12 in total

1.  Thermally enhanced radioresponse of cultured Chinese hamster cells: inhibition of repair of sublethal damage and enhancement of lethal damage.

Authors:  E Ben-Hur; M M Elkind; B V Bronk
Journal:  Radiat Res       Date:  1974-04       Impact factor: 2.841

2.  Interstitial thermoradiotherapy in recurrent gynecologic malignancies.

Authors:  E A Surwit; M R Manning; S A Aristizabal; J R Oleson; T C Cetas
Journal:  Gynecol Oncol       Date:  1983-02       Impact factor: 5.482

3.  Interstitial hyperthermia and interstitial iridium 192 implantation: a technique and preliminary results.

Authors:  C D Joseph; M Astrahan; J Lipsett; J Archambeau; B Forell; F W George
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-06       Impact factor: 7.038

4.  Permanent and removable implants for the brachytherapy of brain tumors.

Authors:  P H Gutin; T L Phillips; Y Hosobuchi; W M Wara; A R MacKay; K A Weaver; S Lamb; S Hurst
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-10       Impact factor: 7.038

Review 5.  Prospects for hyperthermia in human cancer therapy. Part I: hyperthermic effects in man and spontaneous animal tumors.

Authors:  R C Miller; W G Connor; R S Heusinkveld; M L Boone
Journal:  Radiology       Date:  1977-05       Impact factor: 11.105

6.  Interstitial microwave hyperthermia for brain tumors. Results of a phase-1 clinical trial.

Authors:  M Salcman; G M Samaras
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

7.  Stereotactic interstitial irradiation for the treatment of brain tumors.

Authors:  P H Gutin; Y Hosobuchi; T L Phillips; T A Stupar
Journal:  Cancer Treat Rep       Date:  1981

8.  Stereotactic implantation of iridium192 into CNS neoplasms.

Authors:  P J Kelly; M H Olson; A E Wright
Journal:  Surg Neurol       Date:  1978-12

Review 9.  Interstitial irradiation of brain tumors: a review.

Authors:  M Bernstein; P H Gutin
Journal:  Neurosurgery       Date:  1981-12       Impact factor: 4.654

Review 10.  Hyperthermia for brain tumors: biophysical rationale.

Authors:  M Salcman; G M Samaras
Journal:  Neurosurgery       Date:  1981-09       Impact factor: 4.654

View more
  1 in total

1.  Technique and preliminary results of interstitial irradiation for primary brain tumors.

Authors:  M Salcman; W Sewchand; P P Amin; E H Bellis
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.